Mammalian cell survival studies characterizing multiport negative pi-meson irradiation with the Stanford Medical Pion Generator (SMPG). 1994

G C Li, and P Fessenden, and G M Hahn, and G Fisher, and G Luxton, and M A Bagshaw
Department of Radiology, Stanford University School of Medicine, CA 94305.

Radiobiological measurements have been made under various conditions of muliport pion irradiation using the Stanford Medical Pion Generator (SMPG). Chinese hamster cells (HA-1) were suspended in a tissue-equivalent 25% gelatin/medium solution. Hypoxic and aerobic HA-1 cells were irradiated simultaneously in a cylindrical water tank at either 4 or 16 degrees C. Irradiation at the focus of 60 converging pion beams, at a peak dose rate of 6 rads/min, gave relative biological effectiveness (RBEs) of 2.8, 1.8 and 1.4 at 50, 20 and 5% survival, respectively, and an oxygen enhancement ratio (OER) of 1.7. Plateau irradiation with crossing pion beams, at a peak dose-rate of 3 rads/min, resulted in survival values very close to those obtained with similar doses of 85 kV X-rays. Preliminary studies with large irradiation volumes in broadened pion stopping regions indicate RBEs significantly > 1 for survival > 50%. Supporting microdosimetric data with the SMPG are consistent with the radiobiological results.

UI MeSH Term Description Entries
D008651 Mesons Short-lived elementary particles found in cosmic radiation or produced from nuclear disintegration. Their mass is between that of protons and electrons and they can be negative, positive, or neutral. pi-Mesons (pions) are heavier than mu-mesons (muons) and are proposed for cancer radiotherapy because their capture and disintegration by matter produces powerful, but short-lived, secondary radiation. Muons,Pions,mu-Mesons,pi-Mesons,Meson,Muon,Pion,mu Mesons,mu-Meson,pi Mesons,pi-Meson
D008961 Models, Structural A representation, generally small in scale, to show the structure, construction, or appearance of something. (From Random House Unabridged Dictionary, 2d ed) Model, Structural,Structural Model,Structural Models
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D012062 Relative Biological Effectiveness The ratio of radiation dosages required to produce identical change based on a formula comparing other types of radiation with that of gamma or roentgen rays. Biological Effectiveness, Relative,Effectiveness, Biologic Relative,Effectiveness, Biological Relative,Relative Biologic Effectiveness,Biologic Effectiveness, Relative,Biologic Relative Effectiveness,Biological Relative Effectiveness,Effectiveness, Relative Biologic,Effectiveness, Relative Biological,Relative Effectiveness, Biologic
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

G C Li, and P Fessenden, and G M Hahn, and G Fisher, and G Luxton, and M A Bagshaw
January 1977, International journal of radiation oncology, biology, physics,
G C Li, and P Fessenden, and G M Hahn, and G Fisher, and G Luxton, and M A Bagshaw
February 1977, Radiology,
G C Li, and P Fessenden, and G M Hahn, and G Fisher, and G Luxton, and M A Bagshaw
April 1974, European journal of cancer,
G C Li, and P Fessenden, and G M Hahn, and G Fisher, and G Luxton, and M A Bagshaw
January 1978, International journal of radiation oncology, biology, physics,
G C Li, and P Fessenden, and G M Hahn, and G Fisher, and G Luxton, and M A Bagshaw
August 1979, Radiation and environmental biophysics,
G C Li, and P Fessenden, and G M Hahn, and G Fisher, and G Luxton, and M A Bagshaw
October 1980, International journal of radiation biology and related studies in physics, chemistry, and medicine,
G C Li, and P Fessenden, and G M Hahn, and G Fisher, and G Luxton, and M A Bagshaw
August 1979, Radiation and environmental biophysics,
G C Li, and P Fessenden, and G M Hahn, and G Fisher, and G Luxton, and M A Bagshaw
January 1978, International journal of radiation biology and related studies in physics, chemistry, and medicine,
G C Li, and P Fessenden, and G M Hahn, and G Fisher, and G Luxton, and M A Bagshaw
April 1974, European journal of cancer,
G C Li, and P Fessenden, and G M Hahn, and G Fisher, and G Luxton, and M A Bagshaw
March 1976, International journal of radiation biology and related studies in physics, chemistry, and medicine,
Copied contents to your clipboard!